Medicine's Aaron Burberry studies gut microbiomes and neurodegenerative diseases

Gut bacteria could be a hidden trigger for neurodegenerative diseases

Live Science: Aaron Burberry, assistant professor of pathology at the School of Medicine, said larger gut microbiome studies in ALS/FTD patients and clinical trials testing glycogen degradation as a way to slow disease progression "could begin in a year." The prompt: new research linking inflammatory bacterial sugars in the gut to brain damage in ALS and frontotemporal dementia patients.